pharmaphorum8h
Fabhalta is first FDA-approved therapy for rare disease C3G
Novartis has a third FDA-approved indication for its oral therapy for complement-mediated diseases – Fabhalta – after getting ...
The Healthy @Reader's Digest on MSN20h
28 Heart Health Secrets Cardiologists Want You to Know
Time is a scarce resource at the doctor’s office, with the average visit lasting nearly 19 minutes, according to 2023 research published in Journal of the American Medical Association Health Forum.